In Vivo Efficacy of the New Ketolide Telithromycin (HMR 3647) in Murine Infection Models
We compared the oral antibacterial activities of telithromycin (HMR 3647), a new ketolide drug, in different infections induced in mice by Staphylococcus aureus, Streptococcus pneumoniae, streptococci, enterococci, and Haemophilus influenzae with those of various macrolides and pristinamycin. Unlike...
Bewaard in:
| Gepubliceerd in: | Antimicrob Agents Chemother |
|---|---|
| Hoofdauteurs: | , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
American Society for Microbiology (ASM)
2001
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC90532/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11353612/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.45.6.1688-1692.2001 |
| Tags: |
Geen labels, Wees de eerste die dit record labelt!
|
